We postulated that PRDM6 contributes to HNSCC tumor cell growth likely through dysregulation of immune gene expression based on our findings that PRDM6 is a HNSCC-associated TF that participates in the TF-IRG regulons identified from IRIS3 analysis. Here, TF is linked to neoplasm.